CoChat

Biological Aging Predicts Vulnerability to COVID-19 Severity in UK Biobank Participants

Kuo, Chia-Ling, Pilling, Luke C, Atkins, Janice L, Masoli, Jane A H, Delgado, João, Tignanelli, Christopher, Kuchel, George A, Melzer, David, Beckman, Kenneth B, Levine, Morgan E · 2021 · The Journals of Gerontology: Series A
Cited by 56

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Background: Age and disease prevalence are the 2 biggest risk factors for Coronavirus disease 2019 (COVID-19) symptom severity and death. We therefore hypothesized that increased biological age, beyond chronological age, may be driving disease-related trends in COVID-19 severity. Methods: Using the UK Biobank England data, we tested whether a biological age estimate (PhenoAge) measured more than a decade prior to the COVID-19 pandemic was predictive of 2 COVID-19 severity outcomes (inpatient test positivity and COVID-19-related mortality with inpatient test-confirmed COVID-19). Logistic regression models were used with adjustment for age at the pandemic, sex, ethnicity, baseline assessment centers, and preexisting diseases/conditions. Results: Six hundred and thirteen participants tested positive at inpatient settings between March 16 and April 27, 2020, 154 of whom succumbed to COVID-19. PhenoAge was associated with increased risks of inpatient test positivity and COVID-19-related mortality (ORMortality = 1.63 per 5 years, 95% CI: 1.43–1.86, p = 4.7 × 10−13) adjusting for demographics including age at the pandemic. Further adjustment for preexisting diseases/conditions at baseline (ORM = 1.50, 95% CI: 1.30–1.73 per 5 years, p = 3.1 × 10−8) and at the early pandemic (ORM = 1.21, 95% CI: 1.04–1.40 per 5 years, p = .011) decreased the association. Conclusions: PhenoAge measured in 2006–2010 was associated with COVID-19 severity outcomes more than 10 years later. These associations were partly accounted for by prevalent chronic diseases proximate to COVID-19 infection. Overall, our results suggest that aging biomarkers, like PhenoAge may capture long-term vulnerability to diseases like COVID-19, even before the accumulation of age-related comorbid conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/gerona/glab060

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 16

  1. Yan, 2020, An interpretable mortality prediction model for COVID-19 patients, Nat Mach Intell, 2, 283, 10.1038/s42256-020-0180-7 · DOI · Paper page
  2. Bialek, 2020, Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12-March 16, 2020, Morb Mortal Wkly Rep, 69, 343, 10.15585/mmwr.mm6912e2 · DOI · Paper page
  3. Gold, 2020, Race, ethnicity, and age trends in persons who died from COVID-19—United States, May-August 2020, MMWR Morb Mortal Wkly Rep, 69, 1517, 10.15585/mmwr.mm6942e1 · DOI · Paper page
  4. Kuo, 2020, ApoE e4e4 genotype and mortality with COVID-19 in UK Biobank, J Gerontol A Biol Sci Med Sci, 75, 1801, 10.1093/gerona/glaa169 · DOI
  5. Guan, 2020, Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis, Eur Respir J, 55, 2000547, 10.1183/13993003.00547-2020 · DOI · Paper page
  6. Gentile, 2020, COVID-19 infection in Italian people with diabetes: lessons learned for our future (an experience to be used), Diabetes Res Clin Pract, 162, 10.1016/j.diabres.2020.108137 · DOI
  7. DeCaprio, 2020, Building a COVID-19 vulnerability index, J Med Artif Intell, 10.21037/jmai-20-47 · DOI · Paper page
  8. Tang, 2020, Comparison of hospitalized patients with ARDS caused by COVID-19 and H1N1, Chest, 158, 195, 10.1016/j.chest.2020.03.032 · DOI · Paper page
  9. Sun, 2021, CoVA: an acuity score for outpatient screening that predicts Coronavirus disease 2019 prognosis, J Infect Dis, 223, 38, 10.1093/infdis/jiaa663 · DOI · Paper page
  10. Horvath, 2018, DNA methylation-based biomarkers and the epigenetic clock theory of ageing, Nat Rev Genet, 19, 371, 10.1038/s41576-018-0004-3 · DOI · Paper page
  11. Levine, 2013, Modeling the rate of senescence: can estimated biological age predict mortality more accurately than chronological age?, J Gerontol A Biol Sci Med Sci, 68, 667, 10.1093/gerona/gls233 · DOI · Paper page
  12. Armstrong, 2020, Dynamic linkage of COVID-19 test results between Public Health England’s second generation surveillance system and UK Biobank, Microb Genomics, 6, 1, 10.1099/mgen.0.000397 · DOI · Paper page
  13. Tingley, 2014, Mediation: R package for causal mediation analysis, J Stat Softw, 59, 1, 10.18637/jss.v059.i05 · DOI · Paper page
  14. Kuo, 2020, Genetic associations for two biological age measures point to distinct aging phenotypes, medRxiv
  15. Sierra, 2020, Geroscience and the Coronavirus pandemic: the whack-a-mole approach is not enough, J Am Geriatr Soc, 68, 951, 10.1111/jgs.16489 · DOI
  16. Magder, 1997, Logistic regression when the outcome is measured with uncertainty, Am J Epidemiol, 146, 195, 10.1093/oxfordjournals.aje.a009251 · DOI · Paper page

Cited by

See all 56

Metadata

Authors
Kuo, C.-L., Pilling, L. C., Atkins, J. L., Masoli, J. A. H., Delgado, J., Tignanelli, C., Kuchel, G. A., Melzer, D., Beckman, K. B., & Levine, M. E.
Venue
The Journals of Gerontology: Series A
Published
2021-03-04
Volume
76
Issue
8
Pages
e133-e141
ISSN
  • 1079-5006
  • 1758-535X
Cited by
56
References
12
Language
en
Funders
  • National Institute on Aging
  • National Institutes of Health (R00AG052604, R21AG060018, R33AG061456)
  • University of Exeter Medical School
  • University of Connecticut School of Medicine
  • Medical Research Council (MR/S009892/1)
  • National Institute for Health Research (DRF-2014-07-177)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biological Aging Predicts Vulnerability to COVID-19 Severity in UK Biobank Participants. https://app.cochat.ai/papers/10.1093/gerona/glab060
The paper
Kuo, C.-L., Pilling, L. C., Atkins, J. L., Masoli, J. A. H., Delgado, J., Tignanelli, C., Kuchel, G. A., Melzer, D., Beckman, K. B., & Levine, M. E. (2021). Biological Aging Predicts Vulnerability to COVID-19 Severity in UK Biobank Participants. The Journals of Gerontology: Series A. https://doi.org/10.1093/gerona/glab060

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.